Loading...
Loading...
India's pantoprazole imports from UNITED ARAB EMIRATES total $182.1K across 30 shipments from 1 foreign suppliers. FORWARD WAVE EQUIPMENT TRADING leads with $182.1K in import value; the top 5 suppliers together control 100.0% of this origin. Leading Indian buyers include CHANDRA BHAGAT PHARMA LIMITED. This corridor reflects India's pharmaceutical import demand for pantoprazole — a concentrated sourcing relationship with select suppliers from UNITED ARAB EMIRATES.

FORWARD WAVE EQUIPMENT TRADING is the leading Pantoprazole supplier from UNITED ARAB EMIRATES to India, with import value of $182.1K across 30 shipments. The top 5 suppliers — FORWARD WAVE EQUIPMENT TRADING — collectively account for 100.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | FORWARD WAVE EQUIPMENT TRADING | $182.1K | 30 | 100.0% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | CHANDRA BHAGAT PHARMA LIMITED | $182.1K | 30 | 100.0% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Pantoprazole suppliers from UNITED ARAB EMIRATES to India include FORWARD WAVE EQUIPMENT TRADING. The leading supplier is FORWARD WAVE EQUIPMENT TRADING with import value of $182.1K USD across 30 shipments. India imported Pantoprazole worth $182.1K USD from UNITED ARAB EMIRATES in total across 30 shipments.
India imported Pantoprazole worth $182.1K USD from UNITED ARAB EMIRATES across 30 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Pantoprazole sourced from UNITED ARAB EMIRATES include CHANDRA BHAGAT PHARMA LIMITED. The largest buyer is CHANDRA BHAGAT PHARMA LIMITED with $182.1K in imports across 30 shipments.
The total value of Pantoprazole imports from UNITED ARAB EMIRATES to India is $182.1K USD, across 30 shipments and 1 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
30 Verified Shipments
1 suppliers, 1 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists